Mark Warminger will appeal a High Court ruling that he manipulated NZ stock markets.

New Zealand shares gained, led by Vista Group International and Xero.

NPT will pitch its tie-up with Kiwi Property Group at a special meeting next month.

FMA seeks tighter disclosure of non-GAAP measures that can make companies look better.

GeoOp is sounding out investors for a possible ASX listing.

Childrens' retailer Pumpkin Patch may have been given a lifeline in the form of a buyer.

Shareholders have overwhelmingly backed plans to sell the firm's Taupo wood processing mill and wind up the business.

AFT Pharmaceuticals raised new funds through a redeemable share issue to fuel international growth.

Fletcher Building is in a trading halt pending a review of the financial performance of its construction division.

NZX has appointed Richard Bodman as a director, replacing Alison Gerry who has resigned after five years on the board.

A current and a former employee of logistics and fleet management company Eroad face charges.

Problems with the NZX's trading system has delayed the stock market from opening today.

New Zealand shares rose, with A2 Milk and Sky TV recovering from sell-offs, while Ryman Healthcare and Chorus declined.

Z Energy's decision to hold its annual meeting over the internet has drawn flak from the New Zealand Shareholders Association.

Both cash trading volumes and the value of trading fell on year on the NZX in February, when the bulk of the country's biggest listed companies announced earnings.

Stock market operator the NZX has released its first in-depth report into how it investigates complaints and enforces rule breaches.

A businessman is out to shake up the NZX, saying he feels the company has become too bureaucratic and is not encouraging new listings.

Kate McKenzie became the sole woman at the head of an NZX50 company when she started her new job as Chorus chief executive yesterday.

NZ shares gained, with Port of Tauranga, Metlifecare and Contact Energy rising, while stock market operator NZX dropping after posting its earnings.

NZX annual profit dropped 62 per cent as the stock market operator faced mounting costs from the protracted Ralec litigation.

Shares dropped, led lower by Chorus and Vector on regulation news, while A2 Milk Co and Trilogy gained.

Cosmetic and candle company Trilogy has received a price enquiry from NZX following a significant drop in its share price in the last

New Zealand shares rose, with SkyCity Entertainment Group gaining following its first-half earnings while Tower soared 42 per cent on a takeover bid.

The Tower board said the deal would not impact Tower insurance policies or the rights of policy holders.

Hellaby Holdings will delist from the NZX by March 8, after ASX-listed auto firm Bapcor succeeded in its $352 million takeover.

Harbour Asset Management has sold down its stake in Intueri Education Group.

Contact Energy, which last year said it would focus on reducing debt, is considering a $100 million offer of bonds it plans to list on the NZX debt market.

NZ shares gained, led by A2 Milk Co and Fisher & Paykel Healthcare, while Metro Performance Glass plunged after disappointing investors.

Intueri Education Group will quit Australia by the end of the year after losing federal government subsidies.

Cash trading volumes on the NZX slowed in January, continuing December's trend, while the value of trading rose despite fewer small trades.